Beijing Labtech Instruments Co., Ltd. (SHA:688056)
China · Delayed Price · Currency is CNY 38.13
-0.08 (-0.21%)
At close: Feb 13, 2026
SHA:688056 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 395.12 | 421.35 | 413.27 | 352.42 | 366.07 | 345.86 |
Other Revenue | 2.66 | 2.66 | 2.72 | 2.59 | 2.79 | 2.75 |
| 397.79 | 424.01 | 415.99 | 355 | 368.86 | 348.6 | |
Revenue Growth (YoY) | -6.87% | 1.93% | 17.18% | -3.76% | 5.81% | -8.39% |
Cost of Revenue | 215.95 | 233.07 | 233.99 | 186.33 | 190.5 | 178.9 |
Gross Profit | 181.84 | 190.94 | 182 | 168.67 | 178.36 | 169.71 |
Selling, General & Admin | 92.64 | 97.18 | 102.42 | 84.29 | 76.4 | 67.66 |
Research & Development | 48.6 | 51.27 | 52.22 | 38.4 | 31.38 | 29.34 |
Other Operating Expenses | 2.78 | 1.11 | 0.56 | 1.44 | 1.58 | 0.65 |
Operating Expenses | 142.66 | 151.17 | 156.18 | 125.37 | 110.01 | 101.14 |
Operating Income | 39.17 | 39.77 | 25.82 | 43.31 | 68.35 | 68.57 |
Interest Expense | -0.1 | -0.1 | -0.05 | -0.06 | - | -0.01 |
Interest & Investment Income | 9.4 | 9.11 | 7.82 | 7.96 | 9.37 | 2.98 |
Currency Exchange Gain (Loss) | -1.43 | -1.43 | -0.21 | -0.26 | -0.46 | -2.1 |
Other Non Operating Income (Expenses) | 0.18 | -0.8 | -0.89 | -0.72 | -0.39 | -0.32 |
EBT Excluding Unusual Items | 47.23 | 46.54 | 32.49 | 50.23 | 76.88 | 69.12 |
Impairment of Goodwill | -8.53 | -8.53 | -5.14 | - | - | - |
Gain (Loss) on Sale of Investments | 0.04 | 0.94 | -0.27 | 0.35 | - | - |
Gain (Loss) on Sale of Assets | -0 | -0 | -0 | -0 | 0.01 | -0.05 |
Asset Writedown | -0.99 | - | - | - | - | - |
Legal Settlements | - | - | - | - | 2 | -2 |
Other Unusual Items | 4.78 | 4.79 | 1.34 | 0.62 | 3.03 | 9.34 |
Pretax Income | 42.53 | 43.74 | 28.43 | 51.19 | 81.91 | 76.41 |
Income Tax Expense | 5.93 | 4.59 | 0.87 | 6.57 | 12.5 | 11.12 |
Earnings From Continuing Operations | 36.6 | 39.15 | 27.56 | 44.62 | 69.41 | 65.3 |
Minority Interest in Earnings | - | - | - | - | - | -0.09 |
Net Income | 36.6 | 39.15 | 27.56 | 44.62 | 69.41 | 65.21 |
Net Income to Common | 36.6 | 39.15 | 27.56 | 44.62 | 69.41 | 65.21 |
Net Income Growth | 1.67% | 42.03% | -38.23% | -35.71% | 6.44% | 6.34% |
Shares Outstanding (Basic) | 67 | 66 | 67 | 67 | 67 | 56 |
Shares Outstanding (Diluted) | 67 | 66 | 67 | 67 | 67 | 56 |
Shares Change (YoY) | -0.59% | -1.30% | 0.93% | -0.21% | 19.75% | 11.79% |
EPS (Basic) | 0.55 | 0.59 | 0.41 | 0.67 | 1.04 | 1.17 |
EPS (Diluted) | 0.55 | 0.59 | 0.41 | 0.67 | 1.04 | 1.17 |
EPS Growth | 2.27% | 43.90% | -38.81% | -35.58% | -11.11% | -4.88% |
Free Cash Flow | 55.17 | 50.18 | 16.22 | -19.86 | -28.4 | 80.29 |
Free Cash Flow Per Share | 0.83 | 0.76 | 0.24 | -0.30 | -0.43 | 1.44 |
Dividend Per Share | 0.600 | 0.720 | 0.800 | 0.200 | 0.350 | 0.300 |
Dividend Growth | -34.78% | -10.00% | 300.00% | -42.86% | 16.67% | -16.67% |
Gross Margin | 45.71% | 45.03% | 43.75% | 47.51% | 48.35% | 48.68% |
Operating Margin | 9.85% | 9.38% | 6.21% | 12.20% | 18.53% | 19.67% |
Profit Margin | 9.20% | 9.23% | 6.63% | 12.57% | 18.82% | 18.71% |
Free Cash Flow Margin | 13.87% | 11.83% | 3.90% | -5.59% | -7.70% | 23.03% |
EBITDA | 55.07 | 54.49 | 38.98 | 51.14 | 74.14 | 73.5 |
EBITDA Margin | 13.84% | 12.85% | 9.37% | 14.41% | 20.10% | 21.09% |
D&A For EBITDA | 15.9 | 14.73 | 13.16 | 7.83 | 5.79 | 4.93 |
EBIT | 39.17 | 39.77 | 25.82 | 43.31 | 68.35 | 68.57 |
EBIT Margin | 9.85% | 9.38% | 6.21% | 12.20% | 18.53% | 19.67% |
Effective Tax Rate | 13.94% | 10.49% | 3.07% | 12.83% | 15.26% | 14.55% |
Revenue as Reported | 397.79 | 424.01 | 415.99 | 355 | 368.86 | 348.6 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.